Seoulin Bioscience Co.,Ltd. (KOSDAQ: 038070)

Seoulin Bioscience Co.,Ltd. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	11,113	14,602	8,999	14,973	8,498	4,543
Short-Term Investments	16,778	20,722	41,319	40,360	11,362	17,497
Trading Asset Securities	92.05	90.3	4,962	19,999	-	-
Cash & Short-Term Investments	27,983	35,414	55,280	75,332	19,860	22,040
Cash Growth	-48.82%	-35.94%	-26.62%	279.32%	-9.89%	126.50%
Accounts Receivable	8,960	12,986	6,652	10,137	8,840	8,246
Other Receivables	292.23	1,292	630.36	196.33	68.33	132.08
Receivables	9,260	14,294	7,282	10,333	8,908	8,399
Inventory	22,505	21,785	17,307	13,933	11,748	12,030
Prepaid Expenses	17.03	53.74	51.32	32.59	20.85	26.54
Other Current Assets	2,750	1,408	7,366	5,352	924.78	1,307
Total Current Assets	62,514	72,955	87,287	104,983	41,462	43,803
Property, Plant & Equipment	17,352	18,914	16,491	14,937	14,541	25,920
Long-Term Investments	17,093	17,512	25,555	7,515	6,303	6,084
Goodwill	526.49	526.49	526.49	526.49	526.49	526.49
Other Intangible Assets	409.54	425.08	266.64	230.54	319.14	405.58
Long-Term Deferred Tax Assets	2,289	2,259	1,269	2,766	2,655	1,999
Long-Term Deferred Charges	126.9	156.08	210.96	558.01	1,715	1,879
Other Long-Term Assets	2,448	1,335	3,840	5,051	10,725	89.36
Total Assets	102,778	114,100	135,486	136,566	78,247	80,707
Accounts Payable	8,706	11,428	8,603	10,888	6,450	8,335
Accrued Expenses	425.5	387.97	373.05	329.11	278.89	351.73
Short-Term Debt	1,977	6,120	17,469	15,259	142.7	138
Current Portion of Long-Term Debt	-	-	62.5	256.25	229.9	18.75
Current Portion of Leases	250	271.44	69.22	34.65	3.07	15.59
Current Income Taxes Payable	554.17	700.11	730.13	4,561	749.54	2,700
Other Current Liabilities	4,021	9,122	19,058	28,112	5,679	4,170
Total Current Liabilities	15,934	28,030	46,365	59,440	13,533	15,729
Long-Term Debt	98.6	98.6	98.47	154.85	368.75	81.25
Long-Term Leases	119.53	224.29	86.11	32.85	9.92	4.42
Other Long-Term Liabilities	455.36	253.48	151.59	150	1,781	1,781
Total Liabilities	17,201	28,861	46,701	60,064	16,864	19,444
Common Stock	4,450	4,350	4,250	4,150	4,000	3,750
Additional Paid-In Capital	18,519	18,519	18,519	18,490	18,490	18,490
Retained Earnings	67,690	67,177	68,475	58,805	44,024	40,280
Treasury Stock	-3,501	-3,404	-3,261	-3,062	-2,981	-2,812
Comprensive Income & Other	-3,581	-3,581	-3,581	-3,523	-3,613	-
Total Common Equity	83,577	83,063	84,403	74,861	59,920	59,708
Minority Interest	1,999	2,177	4,382	1,642	1,463	1,555
Shareholders' Equity	85,577	85,239	88,785	76,502	61,383	61,263
Total Liabilities & Equity	102,778	114,100	135,486	136,566	78,247	80,707
Total Debt	2,446	6,714	17,785	15,738	754.35	258.01
Net Cash (Debt)	25,537	28,700	37,495	59,594	19,105	21,782
Net Cash Growth	-26.71%	-23.46%	-37.08%	211.92%	-12.29%	171.74%
Net Cash Per Share	2983.25	3352.15	3528.86	6939.33	2223.21	2502.77
Filing Date Shares Outstanding	8.55	8.56	8.37	8.38	8.27	8.06
Total Common Shares Outstanding	8.55	8.56	8.57	8.59	8.59	8.06
Working Capital	46,580	44,924	40,922	45,543	27,928	28,074
Book Value Per Share	9772.82	9701.74	9844.86	8719.17	6973.14	7411.08
Tangible Book Value	82,641	82,111	83,610	74,104	59,074	58,776
Tangible Book Value Per Share	9663.37	9590.60	9752.35	8631.00	6874.73	7295.39
Land	3,967	4,246	3,721	3,185	3,118	6,593
Buildings	11,494	12,539	11,192	10,642	10,563	18,251
Machinery	1,396	1,474	1,193	851.95	631.66	827.41
Construction In Progress	-	-	6	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.